Welcome to our dedicated page for Zepp Health SEC filings (Ticker: ZEPP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Zepp Health's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Zepp Health's regulatory disclosures and financial reporting.
Zepp Health Corporation submitted a Rule 144 notice reporting securities to be sold in connection with the vesting of Restricted Share Units under its Share Incentive Plan. The filing references ADRs (each representing 16 Class A ordinary shares) and a vesting date of 06/26/2026.
The filing lists numeric fields including 9,836 and other reported figures. The entry identifies the ADR class and the vesting event; timing and the connection to the Share Incentive Plan are stated verbatim.
Zepp Health reported a strong start to 2026, with first‑quarter revenue rising 33.8% year over year to US$51.5 million, driven by new Amazfit products such as Active Max, Active 3 Premium, and T‑Rex Ultra 2. Amazfit‑branded revenue also grew 33.8% year over year, reflecting continued progress in its shift toward premium, Hybrid Training‑focused wearables.
Gross margin improved year over year to 37.7%, producing gross profit of US$19.4 million, but Zepp still posted a GAAP net loss of US$19.6 million and an adjusted net loss of US$17.9 million, both slightly narrower than a year ago. Cash and restricted cash totaled US$103.2 million and inventory fell to US$62.8 million, while cumulative debt retired since 2023 reached US$46.4 million. For the second quarter of 2026, management guides net revenue to US$63.0–68.0 million, implying about 6–14% growth versus the same quarter of 2025.
Zepp Health Corp reports an amended Schedule 13G/A showing 11,477,632 shares of Class A common stock beneficially owned, equal to 10.0% of the class as of 03/31/2026. The filing identifies FIL Limited and affiliated entities as the reporting holders.
The disclosure states that Fidelity Funds - China Focus holds 5,998,048 shares or 5.2% of Class A common stock as of 03/31/2026. Signatures show transactions are reported via power of attorney and include Exhibit 99 references.
Zepp Health Corporation files its annual report detailing a global smart wearables and health-technology business built around Amazfit, Zepp Clarity and Zepp Aura brands. For 2025, it generated $258.9M in revenue and reported a net loss of $40.1M.
The company operates through a Cayman holding structure with significant activities in China conducted via consolidated VIEs, whose revenue contribution fell from 40.1% in 2023 to 8.0% in 2025. Zepp highlights legal and operational risks from PRC regulation, VIE enforceability, data security oversight, and potential impacts of the HFCAA on U.S. trading.
Zepp changed its reporting currency from Renminbi to U.S. dollars in 2024 and effected an ADS ratio change so that one ADS now represents 16 Class A shares. As of December 31, 2025, it had 135,608,316 Class A and 99,277,687 Class B ordinary shares outstanding.
Zepp Health Corp director Xie Bing (Brian) has filed an initial statement of beneficial ownership on Form 3. The filing establishes his status as a director and does not report any insider buy, sell, or other share transactions.
Zepp Health Corp director Lai Jimmy Y. filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as a reporting insider under securities rules and does not report any stock purchases, sales, or other transactions in Zepp Health shares.
Zepp Health Corp Chief Technology Officer Meihui Fan has filed an initial statement of beneficial ownership, detailing existing equity and option interests rather than new trades. The filing lists several option awards over Class A ordinary shares with a conversion or exercise price of US$0.0000, covering 160,000, 200,000, 80,000 and 80,000 underlying Class A shares with expirations between 2031 and 2034. It also reports indirect holdings of 432,000 Class A ordinary shares and 3,450,746 Class B ordinary shares held by Fandler Holding Limited, which is ultimately owned by a trust for Mr. Fan and his family members. In addition, Mr. Fan directly holds 10,000 American depositary shares, with each ADS representing 16 Class A ordinary shares.
Zepp Health Corp Chief Financial Officer Deng Cheng filed an initial ownership report on Form 3, showing direct holdings of 101,500 American depositary shares (ADSs). Each ADS represents 16 Class A ordinary shares, meaning this filing simply discloses his existing equity stake rather than reporting a new stock transaction.
Zepp Health Corp executive Wang Hui, VP of Corporate Strategy, has filed an initial ownership report showing a substantial equity stake. He directly holds 1,495,500 Class A ordinary shares and several option awards over additional Class A shares, each with a $0.0000 exercise price and expirations ranging from 2030 to 2034. These entries reflect existing holdings rather than new market purchases or sales.
Zepp Health Corp director and Chief Operating Officer Mike Yan Yeung filed an initial ownership report showing his holdings in the company. He reported Class A ordinary shares and separate holdings of American depositary shares (ADSs). Each ADS represents 16 Class A ordinary shares, according to the disclosure.